Form 8-K - Current report:
SEC Accession No. 0001477932-16-009484
Filing Date
2016-04-05
Accepted
2016-04-04 18:44:34
Documents
7
Period of Report
2016-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctxr_8k.htm 8-K 83600
2 AGREEMENT AND PLAN OF MERGER ctxr_ex21.htm EX-2.1 298891
3 AMENDED AND RESTATED BY-LAWS ctxr_ex31.htm EX-3.1 110551
4 EMPLOYMENT AGREEMENT ctxr_ex101.htm EX-10.1 70516
5 SUBSCRIPTION AGREEMENT ctxr_ex102.htm EX-10.2 24654
6 VOTING AGREEMENT ctxr_ex103.htm EX-10.3 41065
7 PRESS RELEASE ctxr_ex991.htm EX-99.1 12133
  Complete submission text file 0001477932-16-009484.txt   643108
Mailing Address 63 GREAT ROAD MAYNARD MA 01754
Business Address 63 GREAT ROAD MAYNARD MA 01754 (978) 938-0338
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55532 | Film No.: 161552487
SIC: 3714 Motor Vehicle Parts & Accessories